1. A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer
   Miguel A. Villalona-Calero et al, 2004, Clinical Cancer Research CrossRef
2. Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced Cancer
   J. Nemunaitis et al, 1999, Journal of Clinical Oncology CrossRef